Table S1 from Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Pre-surgical (neoadjuvant) immune checkpoint blockade has shown promising activity in multiple cancer types, but the molecular mechanisms are not well understood. Here, we characterized early kinetic
Our understanding of T-cell receptor (TCR) repertoire diversity and response tochallenge is still incomplete. For example, TCR clones shared by different individuals withminimal alteration to germline
GP66:I-A b+ spleen T cells were sorted from LCMV infected animals either 7 or 21 days after Clone 13 infection, conditions referred to as Early and Late Chronic. In addition, similar populat
B6 mice were immunized with either 2000 cfu of ova expressing Listeria monocytogenes (LM-ova) or 100ug whle ovalbumin adjuvanted with 50ug polyIC + 50ug anti-CD40 (FGK45). 7 days later, tetramer stain
Supplemental table 6 for article titled "T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals" by Naranbhai and Nathan et al. CD8+ T cell epitopes in the SA
